CagriSema (Novo Nordisk), a combination drug that includes semaglutide and cagrilintide, is a GLP-1/amylin dual agonist currently in phase 3 trials
There is no established pharmacokinetic or pharmacodynamic interaction between magnesium supplements and GLP-1 receptor agonists or tirzepatide
Theres plenty of encouraging news for people taking GLP-1 drugs like Ozempic to lose weight and reduce the risk of diabetes: countless people who have lost weight while using it and seen other health benefits as a result
Wadden TA, Bailey TS, Billings LK, Davies M, Frias JP, Koroleva A, Lingvay I, ONeil PM, Rubino DM, Skovgaard D, et al
Cardiovascular Health and Muscle Recovery L-carnitine supports cardiovascular health through multiple mechanisms